Balyasny Asset Management LLC Poseida Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.76 - $4.13 $156,870 - $234,736	56,837 New	56,837 $181,000
Q1 2023 May 15, 2023	SELL	$3.08 - $8.73 $34,061 - $96,545	-11,059 Reduced 41.5%	15,592 $48,000
Q4 2022 Feb 14, 2023	BUY	$3.33 - $6.38 $88,747 - $170,033	26,651 New	26,651 $141,000
Q3 2021 Nov 15, 2021	SELL	$7.09 - $10.71 $568,632 - $858,963	-80,202 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.96 - $10.07 $638,407 - $807,634	80,202 New	80,202 $804,000

38.5M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $810M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.